E-LIB Suche - Ergebnisse für: Petrillo, J.

1

EORTC stomach cancer PD-L1 biomarker European initiative: t..:

Petrillo, A. ; Oudijk, L. ; Sundar, R....
ESMO Gastrointestinal Oncology. 5 (2024) - p. 100071 , 2024

Link: https://doi.org/10.1016/..

2

Controversies in upper GI oncology: early-onset gastric can..:

Petrillo, A. ; Alsina, M. ; Ben-Aharon, I.
ESMO Open. 9 (2024) 5 - p. 102925 , 2024

Link: https://doi.org/10.1016/..

3

OC.07.1: CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED ..:

Onali, S. ; Di Petrillo, A. ; Raho, N....
Digestive and Liver Disease. 56 (2024) - p. S161 , 2024

Link: https://doi.org/10.1016/..

4

465P Timing of first-line palliative systemic therapy in me..:

Kamp, D. ; May, A.M. ; Adenis, A....
Annals of Oncology. 35 (2024) - p. S186-S187 , 2024

Link: https://doi.org/10.1016/..

5

BOC.04.1: ANALYSIS OF IMMUNOLOGICALVARIABLES IN EX VIVO TOF..:

Onali, S. ; Di Petrillo, A. ; Soddu, P....
Digestive and Liver Disease. 56 (2024) - p. S120-S121 , 2024

Link: https://doi.org/10.1016/..

6

Controversies in upper GI oncology: MSI-H in gastroesophage..:

Petrillo, A. ; Derks, S. ; Smyth, E.C.
ESMO Open. 9 (2024) 2 - p. 102229 , 2024

Link: https://doi.org/10.1016/..

7

P470 Crohn's disease patients with Ustekinumab-induced remi..:

Onali, S ; Di Petrillo, A ; Raho, N...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i944-i946 , 2024

Link: https://doi.org/10.1093/..

8

P537 Analysis of immunological VAriables in ex vivo Tofacit..:

Onali, S ; Di Petrillo, A ; Soddu, P...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1055-i1056 , 2024

Link: https://doi.org/10.1093/..

9

OC.03.1: ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTH..:

Di Petrillo, A. ; Onali, S. ; Favale, A....
Digestive and Liver Disease. 56 (2024) - p. S133-S134 , 2024

Link: https://doi.org/10.1016/..

10

P011 Altered Expression and Enzymatic Activity of Xanthine ..:

Di Petrillo, A ; Onali, S ; Era, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i260-i260 , 2024

Link: https://doi.org/10.1093/..

11

Regorafenib monotherapy as second-line treatment of patient..:

Cardone, C. ; De Stefano, A. ; Rosati, G....
ESMO Open. 8 (2023) 1 - p. 100748 , 2023

Link: https://doi.org/10.1016/..

12

T.10.5 ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHIN..:

Di Petrillo, A. ; Onali, S. ; Fais, A....
Digestive and Liver Disease. 55 (2023) - p. S180 , 2023

Link: https://doi.org/10.1016/..

13

T.06.1 CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED RE..:

Onali, S. ; Di Petrillo, A. ; Favale, A....
Digestive and Liver Disease. 55 (2023) - p. S159 , 2023

Link: https://doi.org/10.1016/..

14

Controversies in upper GI oncology: first-line checkpoint i..:

Petrillo, A. ; Maron, S.B. ; Sundar, R.
ESMO Open. 8 (2023) 3 - p. 101211 , 2023

Link: https://doi.org/10.1016/..

15

Controversies in upper gastrointestinal oncology: neoadjuva..:

Petrillo, A. ; Lorenzen, S. ; van Laarhoven, H.W.M.
ESMO Open. 7 (2022) 6 - p. 100613 , 2022

Link: https://doi.org/10.1016/..